Obesity and body mass index in the U.S. have decreased for the first time in more than a decade.
The most notable drop was in the South, which also had the highest observed dispensing rate of the type 2 diabetes drug GLP-1RA, researchers said Friday. Semaglutide is one of those drugs and is the basis for commonly used weight loss medications like Ozempic and Wegovy.